EichorEICHOR
Condition: Papillomavirus Infections Synced from ClinicalTrials.gov · August 06, 2026

Recruiting studies: Papillomavirus Infections

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Reducing Urban Cervical Cancer Disparities
NA · 3 location(s) · Fox Chase Cancer Center · NCT06416150Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After H
Phase 2 · 3 location(s) · Universiteit Antwerpen · NCT07407569Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
Phase N/A · 2 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT05371353Multicenter Real-World Study of Hyperthermia in Warts of Special Population
NA · 1 location(s) · First Hospital of China Medical University · NCT06827938Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts
Phase 2/Phase 3 · 2 location(s) · Western Institute for Veterans Research · NCT05625633Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections.
Phase 4 · 12 location(s) · Labo'Life · NCT04232917Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens
Phase N/A · 1 location(s) · European Institute of Oncology · NCT06327568A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC.
Phase 1/Phase 2 · 2 location(s) · Cellid Co., Ltd. · NCT06797986Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05026138Characteristics of Human Papillomavirus (HPV) Infections and HPV Vaccine Attitudes Among Slovenian Women After the Intro
NA · 1 location(s) · University Medical Centre Ljubljana · NCT06995157Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
Phase 3 · 6 location(s) · Verrica Pharmaceuticals Inc. · NCT07246590Zopa Retreatment and Vector Shedding in Adults With RRP
Phase 4 · 3 location(s) · Precigen, Inc · NCT06538480Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants
Phase 2 · 2 location(s) · Frantz Viral Therapeutics, LLC · NCT06206564Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
Phase 4 · 1 location(s) · The University of Texas Medical Branch, Galveston · NCT05672927Comparison of Efficacy of Topical Adaplene Gel Versus Crythotherapy in Recurrent Plantar Warts
Phase 4 · 1 location(s) · Khyber Teaching Hospital · NCT07016360Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening
NA · 5 location(s) · The Institute of Molecular and Translational Medicine, Czech · NCT07033091Concordance and Acceptability of Self-screening Versus Screening by a Healthcare Professional for HPV, a Risk Factor for
NA · 2 location(s) · Centre Hospitalier Universitaire de la Réunion · NCT06507917Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
NA · 4 location(s) · University of California, Irvine · NCT07209917Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
NA · 3 location(s) · Qurasense · NCT07281599Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children With Palmoplantar Wart
NA · 1 location(s) · Mazandaran University of Medical Sciences · NCT06737406Gut and Vaginal Microbiota Profile Study for HIV Women
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT05996016Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
NA · 18 location(s) · National Cancer Institute (NCI) · NCT07281430Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)
Phase 3 · 4 location(s) · Verrica Pharmaceuticals Inc. · NCT07457918Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV
Phase 4 · 1 location(s) · Louisiana State University Health Sciences Center in New Orl · NCT05266898Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine
NA · 1 location(s) · Karolinska Institutet · NCT07275333A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women A
Phase 4 · 1 location(s) · Miquel Angel Pavon Ribas · NCT05334706Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06598475Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
Phase N/A · 1 location(s) · The Institute of Molecular and Translational Medicine, Czech · NCT05774561Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts
NA · 2 location(s) · First Hospital of China Medical University · NCT07565350
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.